CDK2-IN-28
CDK2-IN-28 (compound 22) is a CDK2 inhibitor with good selectivity and cellular effects against other CDKs. CDK2-IN-28 has anti-proliferative effects on MKN1 cells (EC50: 0.31 μM) [1].
Product Specifications
CAS Number
3025006-64-5
UNSPSC
12352005
Target
CDK
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/cdk2-in-28.html
Solubility
10 mM in DMSO
Smiles
CS(C1=CC=C(CN2)C(OCCCCCN(CC3CNC3)C4=NC5=C(C(C)C)C=NN5C2=N4)=C1)(=O)=O
Molecular Formula
C25H35N7O3S
Molecular Weight
513.66
References & Citations
[1]Niu P, et al. Discovery of novel macrocyclic derivatives as potent and selective cyclin-dependent kinase 2 inhibitors. Bioorg Med Chem. 2024 Apr 15;104:117711.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
CDK2; CDK5; CDK7; CDK9
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LV756040 1.0 µg DNA
XBP1P1 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)
Sign In for Pricing
View Details GTR15212802 1 Vial
Lentiviral mouse Disc1 shRNA (UAS) - Lentiviral mouse Disc1 shRNA (UAS) (100)
Sign In for Pricing
View Details OR92611-01 100 mg
[1,1':4',1'':4'',1'''-Quaterphenyl]-3,3''',5,5'''-tetracarboxylic acid
Sign In for Pricing
View Details OR92611-02 250 mg
[1,1':4',1'':4'',1'''-Quaterphenyl]-3,3''',5,5'''-tetracarboxylic acid
Sign In for Pricing
View Details